| Financial Year |
March 31 2023 |
| Monetary Funds |
9,770,572,058.88 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
69,077,608.47 |
| Accounts Receivable |
9,311,578,187.38 |
| Advances to Suppliers |
2,347,309,195.30 |
| Other Receivables |
854,239,320.40 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
2,000,000.00 |
| Inventories |
11,718,104,650.81 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
517,851,423.59 |
| Other Current Assets |
1,659,392,587.20 |
| Total Current Assets |
37,734,496,809.24 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
973,543,050.41 |
| Investment Properties |
-- |
| Fixed Assetes |
22,512,069,463.77 |
| Under-construction Projects |
3,025,035,710.91 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,728,458,928.69 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
319,570,289.58 |
| Deferred Income Tax Assets |
847,300,277.33 |
| Other Non-Current Assets |
5,448,580,146.07 |
| Sub-Total of Non-Current Assets |
36,352,741,970.23 |
| Total Assets |
74,087,238,779.47 |
| Short-Term Loans |
665,092,093.02 |
| Trading Financial liabilities |
-- |
| Notes Payable |
12,001,965,102.82 |
| Accounts Payable |
7,239,788,354.56 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
552,932,652.74 |
| Taxes Payable |
628,248,341.05 |
| Interest Payable |
-- |
| Dividend Payable |
15,490,934.75 |
| Other payables |
5,890,882,645.44 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,661,009,541.79 |
| Other Current Liabilities |
351,180,269.59 |
| Sub-Total of Current Liabilities |
33,641,827,173.50 |
| Long-term Loans |
1,757,097,878.43 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
1,935,629,882.30 |
| Special Payable |
-- |
| Estimatied Liabilities |
1,325,118,317.83 |
| Deferred Income Tax Liabilities |
520,328,250.21 |
| Other Non-Current Liabilities |
183,875,914.00 |
| Sub-Total of Non-Current Liabilities |
7,559,693,351.75 |
| Total Liabilities |
41,201,520,525.25 |
| Paid-In Capital(Or Share Stock) |
2,356,623,764.00 |
| Capital Surplus |
14,032,945,117.41 |
| Surplus Reserve |
531,983,909.75 |
| LESS:Treasury Stock |
154,494,371.80 |
| Undistributed Profits |
13,377,793,914.23 |
| Minority Stockholder's Interest |
2,766,484,993.21 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
30,119,233,261.01 |
| Owner's Equity（Stockholder's Equity） |
32,885,718,254.22 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
74,087,238,779.47 |
